Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 May 12;23(1):189.
doi: 10.1186/s12883-023-03214-6.

Anti-ganglioside antibody positive neuromyelitis optica spectrum disorders with peripheral neuropathy: a case report

Affiliations
Case Reports

Anti-ganglioside antibody positive neuromyelitis optica spectrum disorders with peripheral neuropathy: a case report

Yangchun Li et al. BMC Neurol. .

Abstract

Background: Neuromyelitis optica spectrum disorders (NMOSD) is a group of autoimmune-mediated disorders of the central nervous system primarily involving the optic nerve and spinal cord. There are limited reports of NMOSD associated with peripheral nerve damage.

Case presentation: We report a 57-year-old female patient who met the diagnostic criteria for aquaporin 4 (AQP4)-IgG positive NMOSD with undifferentiated connective tissue disease and multiple peripheral neuropathy. In addition, the patient was positive for multiple anti-ganglioside antibodies (anti-GD1a IgG antibodies and anti-GD3 IgM antibodies) and anti-sulfatide IgG antibodies in serum and cerebrospinal fluid. After treatment with methylprednisolone, gamma globulin, plasma exchange, and rituximab, the patient's status improved and was subsequently discharged from our hospital.

Conclusions: The neurologist should be aware of the unusual association between NMOSD and immune-mediated peripheral neuropathy undifferentiated connective tissue disease and nerve damage mediated by multiple antibodies may have combined to cause peripheral nerve damage in this patient.

Keywords: Anti-ganglioside antibody; Neuromyelitis optica spectrum disorders; Peripheral neuropathy; Undifferentiated connective tissue disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
MRI findings of cervical cord. A and Prior to treatment, MRI showed myelopathyfrom medulla oblongata to spinal cord C3; C and MRI reexamination showed that the range of myelopathy was enlarged to spinal cord C5. White arrow indicates the lesion. A and C are T2-weighted images, while B and D are T1-weighted images

Similar articles

References

    1. Costello F. Neuromyelitis Optica Spectrum Disorders. Continuum (Minneap Minn) 2022;28(4):1131–1170. - PubMed
    1. Hor JY, Asgari N, Nakashima I, Broadley SA, Leite MI, Kissani N, et al. Epidemiology of Nezuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide. Front Neurol. 2020;26(11):501. doi: 10.3389/fneur.2020.00501. - DOI - PMC - PubMed
    1. Oh J, Levy M. Neuromyelitis optica: an antibody-mediated disorder of the central nervous system. Neurol Res Int. 2012;2012:460825. doi: 10.1155/2012/460825. - DOI - PMC - PubMed
    1. Antunes M, Scirè CA, Talarico R, Alexander T, Avcin T, Belocchi C, et al. Undifferentiated connective tissue disease: state of the art on clinical practice guidelines. RMD Open. 2019;4(Suppl 1):e000786. doi: 10.1136/rmdopen-2018-000786. - DOI - PMC - PubMed
    1. Ma X, Kermode AG, Hu X, Qiu W. Risk of relapse in patients with neuromyelitis optica spectrum disorder: Recognition and preventive strategy. Mult Scler Relat Disord. 2020;46:102522. doi: 10.1016/j.msard.2020.102522. - DOI - PubMed

Publication types